Live
Everstone Group, an Indian private equity firm has acquired Malaysian medical devices firm Chemopharm, for an amount which is not disclosed.
As per Amit Manocha, Everstone Group’s managing director, “Everstone has significant experience in the healthcare sector and this is its fourth investment and (we) will be looking at more opportunities in this space.”
Chemopharm has its headquarter’s in Malaysia and has operations in Singapore, Thailand, Indonesia, Vietnam and the Philippines. It has a customer base of over 4,000, which includes hospitals, labs and research facilities.
